Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
ProMIS Neurosciences Inc. (PMN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/22/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E... |
| 08/14/2023 |
8-K
| Quarterly results |
| 07/14/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 07/10/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 06/30/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/15/2023 |
8-K
| Quarterly results |
| 05/08/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 04/03/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/08/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 11/16/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
8-K
| Quarterly results |
| 10/17/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"AMENDED AND RESTATED PLACEMENT AGENT AGREEMENT",
"AMENDMENT NO. 1 TO AMENDED AND RESTATED PLACEMENT AGENT AGREEMENT",
"ProMis Neurosciences Inc.",
"ProMis Neurosciences Inc. WARRANT TO PURCHASE COMMON SHARES",
"PROMIS NEUROSCIENCES INC. UNIT PURCHASE AGREEMENT",
"Registration Rights Agreement",
"ProMIS Neurosciences Announces Closing of US $7.4 Million Private Placement Toronto, Ontario and Cambridge, MA – October 12, 2022 – ProMIS Neurosciences Inc. , a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic misfolded proteins implicated in the development of neurodegenerative diseases such as Alzheimer’ s disease , amyotrophic lateral sclerosis and multiple system atrophy , today announced that it has closed a fully subscribed private placement of 1,383,755 Units of the Company at a price of US$5.40 per Unit for gross proceeds of US$7,472,277. Each Unit is comprised of one Common Share of the Company and one quarter of one Common Share purchase Warrant. Each full Warrant is exercisable for one Common Share at US$7.50 for a period o..." |
|
| 09/13/2022 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 08/15/2022 |
8-K
| Quarterly results |
| 07/29/2022 |
8-K
| Quarterly results |
| 07/08/2022 |
8-K
| Quarterly results |
|
|